首頁 › 子宮內膜癌 › 維吉尼亞州 › Arlington
Arlington, VA 的 子宮內膜癌 臨床試驗
39 項針對 子宮內膜癌 的研究正在 Arlington（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
招募中2 期
- Inova Fairfax Hospital, Falls Church · 距離 4 英里
- Inova Schar Cancer Institute, Fairfax · 距離 11 英里
Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
招募中1/2 期
- Research Site, Fairfax · 距離 11 英里
A Study of PHST001 in Advanced Solid Tumors
招募中1 期
- NEXT Oncology - Virginia, Fairfax · 距離 11 英里
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
招募中1 期
- Inova Schar Cancer Institute, Fairfax · 距離 11 英里
- NEXT Virginia, Fairfax · 距離 11 英里
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
招募中1/2 期
- Virginia Cancer Specialists, Fairfax · 距離 11 英里
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
招募中1 期
- NEXT Virginia, Fairfax · 距離 11 英里
A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors
招募中1 期
- Site 04, Fairfax · 距離 11 英里
Study of AVZO-021 in Patients With Advanced Solid Tumors
招募中1/2 期
- Avenzo Therapeutics Recruiting Site, Fairfax · 距離 11 英里
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
招募中1/2 期
- NEXT Oncology Virginia, Fairfax · 距離 11 英里
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
招募中1 期
- Virginia Cancer Specialists, Fairfax · 距離 11 英里
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
招募中3 期
- Inova Schar Cancer Institute ( Site 6003), Fairfax · 距離 11 英里
- Virginia Cancer Specialists (VCS) ( Site 8008), Fairfax · 距離 11 英里
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
招募中1/2 期
- NEXT Oncology, Fairfax · 距離 11 英里
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
招募中1 期
- Virginia Cancer Specialists, Fairfax · 距離 11 英里
Phase 1 Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of ARR-002 in Advanced or Metastatic Ovarian or Endometrial Cancer.
招募中1 期
- NEXT Oncology, Fairfax · 距離 11 英里
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
招募中3 期
- Research Site, Fairfax · 距離 11 英里
A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
招募中1 期
- NEXT Virginia, Fairfax · 距離 11 英里
A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors
招募中1 期
- NEXT Virginia, Fairfax · 距離 11 英里
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
招募中1 期
- Inova Schar Cancer Institute, Falls Church · 距離 4 英里
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
招募中1 期
- Normunity Investigational Site, Fairfax · 距離 11 英里
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
招募中1/2 期
- Virginia Cancer Specialists, Fairfax · 距離 11 英里
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
招募中1 期
- NEXT Oncology - Virginia Cancer Specialists, Fairfax · 距離 11 英里
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
招募中1/2 期
- USOR Virginia Cancer Specialists, Fairfax · 距離 11 英里
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
招募中1/2 期
- Virginia Cancer Specialists, Fairfax · 距離 11 英里
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
招募中3 期
- Research Site, Falls Church · 距離 4 英里
- Research Site, Fairfax · 距離 11 英里
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
招募中1 期
- NEXT Virginia, Fairfax · 距離 11 英里
Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors
招募中1 期
- NEXT Virginia, Fairfax · 距離 11 英里
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
招募中2 期
- 522, Fairfax · 距離 11 英里
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
招募中1/2 期
- USO-Virginia Cancer Specialists, PC, Fairfax · 距離 11 英里
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
招募中1 期
- NEXT Virginia, Fairfax · 距離 11 英里
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
招募中1/2 期
- NEXT Oncology Virginia, Fairfax · 距離 11 英里
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
招募中1/2 期
- NEXT, Fairfax · 距離 11 英里
A Study of LY4175408 in Participants With Advanced Cancer
招募中1 期
- NEXT Virginia, Fairfax · 距離 11 英里
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
招募中1 期
- NEXT Texas LLC - Virginia, Fairfax · 距離 11 英里
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
招募中1/2 期
- Virginia Cancer Specialists, Fairfax · 距離 11 英里
First in Human Study of TORL-1-23 in Participants With Advanced Cancer
招募中1 期
- Virginia Cancer Specialists, Fairfax · 距離 11 英里
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
招募中1 期
- Dren Investigational Site, Fairfax · 距離 11 英里
Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer
招募中2 期
- Virginia Cancer Specialists, P.C., Fairfax · 距離 11 英里
Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
招募中1 期
- Virginia Cancer Specialists, Fairfax · 距離 11 英里
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
招募中1/2 期
- Virginia Cancer Specialists, Fairfax · 距離 11 英里
其他城市的 子宮內膜癌 試驗
- Houston, TX68 項研究
- New York City, NY52 項研究
- Boston, MA50 項研究
- Nashville, TN38 項研究
- Los Angeles, CA34 項研究
- St. Louis, MO29 項研究
- Philadelphia, PA28 項研究
- San Antonio, TX27 項研究
- Columbus, OH25 項研究
- Oklahoma City, OK25 項研究
- Chicago, IL25 項研究
- Queens, NY25 項研究
Arlington 的其他研究
- 非小細胞肺癌104 項研究
- 轉移性癌症53 項研究
- 大腸直腸癌52 項研究
- 癌症（所有類型）48 項研究
- 乳癌47 項研究
- 卵巢癌46 項研究
- 肺癌41 項研究
- 胰臟癌33 項研究
- 頭頸部鱗狀細胞癌26 項研究
- 小細胞肺癌23 項研究
- 胃癌20 項研究
- 三陰性乳癌20 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。